WAYNE, PA – June 08, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, Calif. – May 16, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, Calif. and Boston – May 15, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, Calif. and LONDON – March 27, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, CA, US March 23, 2017 – NeoTract, Inc., announced today that the largest private health insurer in Ireland, Vhi Group,... Read More
LONDON –The UroLift System treatment for enlarged prostate has been highlighted as a strategically important product for the future of the NHS,... Read More
Results and patient experience may vary. While UroLift® is safe, some side effects may occur. As with any medical procedure,... Read More
NeoTract, Inc., a medical device company focused on addressing unmet needs in urology, today announced that the company’s UroLift® System received the Phoenix 2016 Most Promising New Product Award at the 23rd Annual Phoenix Conference in Laguna Beach,... Read More
PLEASANTON, Calif. – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced the peer-reviewed publication of four-year follow-up data from the pivotal,... Read More
TOLEDO, SPAIN 16 June, 2016 –The UroLift® System treatment for enlarged prostate is to be showcased tomorrow (June 17) at the Spanish National Congress of Urology meeting in Toledo,... Read More
US
AU
UK